Stephanie Willing

Stephanie works in the Life Sciences team, with a particular focus on biotechnological inventions including therapeutic proteins, antisense compounds and microbial processes. Her experience includes global prosecution of patent portfolios, management of European SPC portfolios and attacking and defending patents in post-grant opposition and appeal proceedings at the EPO.

Having graduated from UCL with first class honours in Biochemistry, Stephanie went onto complete an MRes in Biochemical Research and a PhD in Molecular Microbiology from Imperial College London. She then conducted postdoctoral research at the University of Chicago, where she studied regulatory mechanisms of peptidoglycan biosynthesis in Staphylococcus aureus. Prior to joining Carpmaels & Ransford, Stephanie worked as an Analyst performing scientific, commercial and intellectual property due diligence for the Opportunity Assessment Group at LifeArc, a medical research charity.

Outside of the office, Stephanie is a keen runner and enjoys traveling to new places to run marathons.